First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.

BACKGROUND We aimed to evaluate efficacy and safety of left atrial appendage (LAA) closure with the new Watchman FLX and analyze procedural features in a consecutive series of high risk non-valvular atrial fibrillation patients. METHODS AND RESULTS Twelve consecutive non-valvular atrial fibrillation patients (age 76.6±7.8years) at high risk for stroke… CONTINUE READING